BERLIN, 15 September 2022 – Ariceum Therapeutics (Ariceum), a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers, today announces that its senior management team will be attending and hosting meetings at the following investor and scientific conferences in the fourth quarter of 2022. Read more…
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on its brilliant events coming up in 2022.
Watch a replay of the live session here or read our top takeaways below…
– World Class Speakers from Biotech & Healthcare Industry and Investment Community – Building the Future Industry ‘Champions’ LONDON, Sept. 30, 2021 /PRNewswire/ — Optimum Strategic Communications (Optimum), the International Strategic Healthcare Communications firm, will be hosting its 13th Annual Healthcare Investor Conference on Monday, 4 October 2021. Firmly established as a major thought leadership event in the European healthcare sector’s calendar, eminent […]
In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.
